The FDA is now mandating GLP-1 weight loss drugs carry a warning label that the medications carry “a potential increased risk” of a rare eye condition that may cause permanent vision loss. The FDA is now mandating GLP-1 weight loss drugs carry a warning label that the medications carry “a potential increased risk” of a rare…
Taking a short midday snooze can be a good way to recharge and give your brain a boost so Dr. Saema Tahir, a sleep and pulmonary specialist, joins TODAY with everything you need to know, including the biggest mistakes people make when napping. Taking a short midday snooze can be a good way to recharge and…
Sissy Goff and David Thomas, licensed professional counselors and New York Times bestselling authors of “Capable: How to Teach Your Kids the Strengths, Skills and Strategies to Build Reslience,” join TODAY to discuss ways that moms and dads can give themselves grace and enjoy the overwhelming holiday season. Sissy Goff and David Thomas, licensed professional counselors…
There’s a new alert on those popular GLP-1 weight loss drugs. The FDA is now mandating a warning label that the drugs may cause sudden blindness. NBC News’ Stephanie Gosk reports. There’s a new alert on those popular GLP-1 weight loss drugs. The FDA is now mandating a warning label that the drugs may cause sudden…
The FDA is now mandating GLP-1 weight loss drugs carry a warning label that the medications carry “a potential increased risk” of a rare eye condition that may cause permanent vision loss. The FDA is now mandating GLP-1 weight loss drugs carry a warning label that the medications carry “a potential increased risk” of a rare…
Taking a short midday snooze can be a good way to recharge and give your brain a boost so Dr. Saema Tahir, a sleep and pulmonary specialist, joins TODAY with everything you need to know, including the biggest mistakes people make when napping. Taking a short midday snooze can be a good way to recharge and…
Sissy Goff and David Thomas, licensed professional counselors and New York Times bestselling authors of “Capable: How to Teach Your Kids the Strengths, Skills and Strategies to Build Reslience,” join TODAY to discuss ways that moms and dads can give themselves grace and enjoy the overwhelming holiday season. Sissy Goff and David Thomas, licensed professional counselors…
There’s a new alert on those popular GLP-1 weight loss drugs. The FDA is now mandating a warning label that the drugs may cause sudden blindness. NBC News’ Stephanie Gosk reports. There’s a new alert on those popular GLP-1 weight loss drugs. The FDA is now mandating a warning label that the drugs may cause sudden…
The Food and Drug Administration said Monday that GLP-1 drugmakers must add a warning label about a rare eye condition that can cause sudden blindness. The Food and Drug Administration said Monday that GLP-1 drugmakers must add a warning label about a rare eye condition that can cause sudden blindness.
An experimental drug that held great promise in driving down a dangerous form of cholesterol didn’t show any measurable impact on heart attack or stroke in a clinical trial. An experimental drug that held great promise in driving down a dangerous form of cholesterol didn’t show any measurable impact on heart attack or stroke in a…
From copper peptides to PDRN made from salmon DNA, social media is filled with advice and viral skin care ingredients, but which products actually deserve a spot in your routine? Board-certified dermatologist Marnie Nussbaum joins TODAY to break it all down. From copper peptides to PDRN made from salmon DNA, social media is filled with advice…
CVS Health says it is splitting in two, putting its retail pharmacy in one unit and its insurance side, which oversees Aetna and Caremark, will be separate. The CEO says the idea is to help customer engagement, affordability and care coordination. CVS Health says it is splitting in two, putting its retail pharmacy in one unit…
After her insurer denied a milder chemotherapy her oncologist prescribed, breast cancer patient Elizabeth Nicholas emailed the CEO — and got it approved 14 hours later. NBC News’ Kate Snow reports. After her insurer denied a milder chemotherapy her oncologist prescribed, breast cancer patient Elizabeth Nicholas emailed the CEO — and got it approved 14 hours…
The infant’s death followed a measles-associated death reported Wednesday in Pennsylvania and another Monday in New York. The infant’s death followed a measles-associated death reported Wednesday in Pennsylvania and another Monday in New York.
